These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30780861)

  • 1. Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial.
    Joshi R; Galan B; Chalmers J; Perkovic V; Patel A
    Expert Rev Endocrinol Metab; 2009 Mar; 4(2):111-118. PubMed ID: 30780861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE.
    Poulter NR
    J Hypertens Suppl; 2009 May; 27(1):S3-8. PubMed ID: 19483505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADVANCE: breaking new ground in type 2 diabetes.
    Chalmers J; Perkovic V; Joshi R; Patel A
    J Hypertens Suppl; 2006 Aug; 24(5):S22-8. PubMed ID: 16936533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights from ADVANCE.
    Chalmers J; Kengne AP; Joshi R; Perkovic V; Patel A
    J Hypertens Suppl; 2007 Jun; 25(1):S23-30. PubMed ID: 17579315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
    Zoungas S; de Galan BE; Ninomiya T; Grobbee D; Hamet P; Heller S; MacMahon S; Marre M; Neal B; Patel A; Woodward M; Chalmers J; ; Cass A; Glasziou P; Harrap S; Lisheng L; Mancia G; Pillai A; Poulter N; Perkovic V; Travert F
    Diabetes Care; 2009 Nov; 32(11):2068-74. PubMed ID: 19651921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation.
    J Hypertens Suppl; 2001 Nov; 19(4):S21-8. PubMed ID: 11848259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
    Zoungas S; Chalmers J; Neal B; Billot L; Li Q; Hirakawa Y; Arima H; Monaghan H; Joshi R; Colagiuri S; Cooper ME; Glasziou P; Grobbee D; Hamet P; Harrap S; Heller S; Lisheng L; Mancia G; Marre M; Matthews DR; Mogensen CE; Perkovic V; Poulter N; Rodgers A; Williams B; MacMahon S; Patel A; Woodward M;
    N Engl J Med; 2014 Oct; 371(15):1392-406. PubMed ID: 25234206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADVANCE: action in diabetes and vascular disease.
    Patel A; Chalmers J; Poulter N
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S27-32. PubMed ID: 16075030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
    Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
    J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation.
    ADVANCE Management Committee
    Diabetologia; 2001 Sep; 44(9):1118-20. PubMed ID: 11596665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.
    Hirakawa Y; Arima H; Zoungas S; Ninomiya T; Cooper M; Hamet P; Mancia G; Poulter N; Harrap S; Woodward M; Chalmers J
    Diabetes Care; 2014 Aug; 37(8):2359-65. PubMed ID: 24812434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ADVANCE study: objectives, design and current status].
    Chalmers J
    Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE.
    Chalmers J; Joshi R; Kengne AP; MacMahon S
    J Hypertens Suppl; 2008 Jun; 26(2):S11-5. PubMed ID: 18979718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of blood pressure lowering in type 2 diabetes: focus on ADVANCE.
    Chalmers J; Arima H
    J Cardiovasc Pharmacol; 2010 Apr; 55(4):340-7. PubMed ID: 20422738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
    ; Patel A; MacMahon S; Chalmers J; Neal B; Billot L; Woodward M; Marre M; Cooper M; Glasziou P; Grobbee D; Hamet P; Harrap S; Heller S; Liu L; Mancia G; Mogensen CE; Pan C; Poulter N; Rodgers A; Williams B; Bompoint S; de Galan BE; Joshi R; Travert F
    N Engl J Med; 2008 Jun; 358(24):2560-72. PubMed ID: 18539916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation.
    van der Leeuw J; Visseren FL; Woodward M; Zoungas S; Kengne AP; van der Graaf Y; Glasziou P; Hamet P; MacMahon S; Poulter N; Grobbee DE; Chalmers J
    Hypertension; 2015 Jan; 65(1):115-21. PubMed ID: 25312436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal protection: What have we learnt from ADVANCE about kidney disease in type 2 diabetes?
    Knudsen ST; Cooper ME
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 2():12-18. PubMed ID: 31729127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.
    Beulens JW; Patel A; Vingerling JR; Cruickshank JK; Hughes AD; Stanton A; Lu J; McG Thom SA; Grobbee DE; Stolk RP; ;
    Diabetologia; 2009 Oct; 52(10):2027-36. PubMed ID: 19633827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
    van Steen SC; Woodward M; Chalmers J; Li Q; Marre M; Cooper ME; Hamet P; Mancia G; Colagiuri S; Williams B; Grobbee DE; DeVries JH;
    Diabetologia; 2018 Apr; 61(4):780-789. PubMed ID: 29308539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.